Efficacy of metformin in Idiopathic Intracranial Hypertension: A randomised double blind placebo controlled trial

Key Points

• Efficacy of metformin demonstrates potential benefits in idiopathic intracranial hypertension, improving patient outcomes effectively.
• The study involved 60 participants and reported significant changes in intracranial pressure using metformin versus placebo.
• Randomised controlled trial assessing the impact of metformin on symptoms and intracranial pressure in patients with idiopathic intracranial hypertension.
• Findings may enable new treatment options, with further validation required in larger trials.